Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Invested Capital (2010 - 2023)

Talphera (TLPH) posted Invested Capital of $14.1 million for Q4 2023, down 22.95% on a QoQ basis from $18.3 million in Q3 2023, and down 48.1% year-over-year from $27.2 million in Q4 2022.

Analysis

Talphera (TLPH) Invested Capital (2010 - 2023) Analysis & Trends

Talphera has reported Invested Capital for 14 years, with the latest figure at $14.1 million in Q4 2023.

  • On a quarterly basis, Invested Capital fell 48.1% year-over-year to $14.1 million in Q4 2023; TTM through Dec 2023 was $14.1 million, a 48.1% decrease from a year earlier, with the FY2023 full-year figure at $14.1 million, down 48.1% from the prior year.
  • Invested Capital was $14.1 million for Q4 2023 at Talphera, down from $18.3 million in the prior quarter.
  • The five-year high for Invested Capital was $43.0 million in Q2 2022, with the low at -$34.1 million in Q3 2020.
  • Average Invested Capital over 5 years is -$3.8 million, with a median of -$5.8 million recorded in 2019.
  • The sharpest annual moves came in 2020 and 2022: Invested Capital plunged 1483.47% in 2020, then soared 341.05% in 2022.
  • Over 5 years, Invested Capital stood at -$16.3 million in 2019, then tumbled by 108.19% to -$33.9 million in 2020, then soared by 34.79% to -$22.1 million in 2021, then soared by 223.03% to $27.2 million in 2022, then sank by 48.1% to $14.1 million in 2023.
  • The last three Invested Capital figures came in at $14.1 million (Q4 2023), $18.3 million (Q3 2023), and $10.4 million (Q2 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 74.44 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 40.49 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 33.70 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 7.35 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 26.94 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Talphera 92.90 Mn 92.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 14.11 Mn
Sep 30, 2023 18.31 Mn
Jun 30, 2023 10.42 Mn
Mar 31, 2023 20.86 Mn
Dec 31, 2022 27.18 Mn
Sep 30, 2022 35.11 Mn
Jun 30, 2022 43.03 Mn
Mar 31, 2022 -26.42 Mn
Dec 31, 2021 -22.09 Mn
Sep 30, 2021 -27.29 Mn
Jun 30, 2021 -17.85 Mn
Mar 31, 2021 -7.30 Mn
Dec 31, 2020 -33.88 Mn
Sep 30, 2020 -34.14 Mn
Jun 30, 2020 -34.10 Mn
Mar 31, 2020 -29.54 Mn
Dec 31, 2019 -16.27 Mn
Sep 30, 2019 -4.27 Mn
Jun 30, 2019 5.35 Mn
Mar 31, 2019 2.14 Mn